文献速递消化道肿瘤与早癌消化内镜

偶发胃底腺息肉伴异型增生的临床病理评估:对临床管理的意义

A Clinicopathologic Evaluation of Incidental Fundic Gland Polyps With Dysplasia: Implications for Clinical Management.
PubMed 文献 · Am J Gastroenterol · 2017-05-02

该研究评估了偶发胃底腺息肉伴异型增生(FGPD)对家族性腺瘤性息肉病(FAP)的阳性预测价值,并描述其临床病理特征。2004至2015年共识别25例无FAP患者的偶发FGPD,占FGPD的11.6%、全部胃底腺息肉的1.0%。随访平均4.4年,无FAP临床证据,11例接受胚系检测者均无APC或MUTYH突变,结论认为偶发FGPD均为散发性,不提示FAP。

要点

  • 偶发FGPD占FGPD的11.6%、全部胃底腺息肉的1.0%。
  • 25例偶发FGPD经内镜、临床和分子 findings 均为散发性(25/25)。
  • 作为孤立发现,FGPD似乎不需要随访遗传咨询或检测。

核心结论

  • 本系列中偶发FGPD经内镜、临床和分子 findings 均为散发性(25/25),因此FGPD并非FAP的前兆。
  • 作为孤立发现,FGPD似乎不需要随访遗传咨询或检测。

研究设计与样本

  • 回顾性识别2004至2015年活检时无FAP患者的偶发FGPD,复习所有临床随访数据,并对同意患者进行APC和MUTYH胚系分析。

主要发现

  • 共识别25例偶发FGPD,占FGPD的11.6%、全部胃底腺息肉的1.0%。
  • 4例患者有胃息肉或胃肠道肿瘤家族史。
  • 临床管理包括完成性息肉切除术和胃镜监测(44%)、仅内镜监测(32%)、无随访(24%)、转诊结肠镜检查(12%)和遗传咨询(4%)。
  • 记录中的结肠镜检查显示0-7个累计腺瘤,随访平均4.4年(范围0.3-10.6)。
  • 无FAP、胃癌、死亡或手术的临床证据;11例同意接受胚系APC和MUTYH检测的患者均无基因组改变。

临床怎么用

  • 作者认为,作为孤立发现的FGPD似乎不需要随访遗传咨询或检测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Fundic gland polyps (FGPs) can rarely exhibit dysplasia of the surface epithelium. Based on retrospective data, FGPs with dysplasia (FGPDs) are thought to be a strong marker for familial adenomatous polyposis (FAP), although sporadic, non-syndromic FGPDs also occur. Owing to the significant syndromic association, diagnosis of an apparently sporadic FGPD may prompt clinical evaluation for FAP, especially its attenuated variant. We sought to evaluate the positive predictive value of incidental FGPDs for FAP. We also characterized the clinicopathologic features of incidental FGPDs to advance clinical management. METHODS: Incidental FGPDs were identified from 2004 to 2015 in patients without FAP at biopsy. All clinical follow-up data were reviewed, and germline analysis for APC and MUTYH mutations was performed in consenting patients. RESULTS: We identified 25 incidental FGPDs in patients not known to have FAP (11.6% of FGPDs, 1.0% of all FGPs). Four patients had a family history of gastric polyps or gastrointestinal cancers. Clinical management included completion polypectomy and gastric endoscopic surveillance (44%), endoscopic surveillance alone (32%), no follow-up (24%), colonoscopy referral (12%), and genetic counseling (4%). Colonoscopies on record revealed 0-7 cumulative adenomas. Follow-up averaged 4.4 years (range 0.3-10.6). No clinical evidence of FAP, gastric cancer, death, or surgery occurred. None of the 11 patients consenting to germline APC and MUTYH testing had genomic alterations. CONCLUSIONS: Incidental FGPDs in this series were all found to be sporadic (25/25) by endoscopic, clinical, and molecular findings, and thus FGPDs were not harbingers of FAP. As isolated findings, FGPDs do not appear to warrant follow-up genetic counseling or testing.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Lloyd IE, Kohlmann WK, Gligorich K, et al. A Clinicopathologic Evaluation of Incidental Fundic Gland Polyps With Dysplasia: Implications for Clinical Management. Am J Gastroenterol. 2017. PMID: 28462913. doi:10.1038/ajg.2017.125

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。